Is It Still Worth Buying GSK After a 46% Rally in Shares This Year
GSK has seen a steep run in its stock, prompting questions about whether the rally still offers upside. This article ...
An accessible primer on stock index levels, detailing what they represent, how they’re calculated, and why they matter for portfolio assessment.
20,792 articlesGSK has seen a steep run in its stock, prompting questions about whether the rally still offers upside. This article ...
IonQ posted full-year revenue of $130 million and a 2026 guidance of $225-245 million, as it leans on defense contrac...
Backlogs can power stock moves, but they also raise questions about execution, risk, and long-term profitability. Thi...
Is GE Vernova the vernova smartest investment make for your portfolio? This comprehensive guide breaks down the busin...
Sarepta Therapeutics surged about 20% after releasing early Phase 1/2 data for SRP-1001 and SRP-1003, signaling poten...
A Russian actor allegedly used forged ties to the Astor name to extract roughly $450 million from a Mexican billionai...
Qualcomm exploded higher, gaining about 70% in a single month as it pivots toward AI data-center demand. Investors ar...
Housing stocks depression mode is taking hold as major builders and appliance makers slump despite a rising S&P 500. ...
As 2026 unfolds, investors are weighing which bank stocks offer durable growth and solid risk controls. This guide br...
As investors eye pagseguro (pags) 2026 earnings, this guide breaks down what to watch, how growth could unfold, and p...
Investors are rethinking where to place bets as AI hype cools. Transportation stocks offer diversification and exposu...
Analysts are scrutinizing Strategy’s STRC funding loop as the near-$100 par anchor tightens. A disruption could tempe...